Pure Global

Coronary stents release the drug Biolimus A9 - Vietnam Registration 1389

Access comprehensive regulatory information for Coronary stents release the drug Biolimus A9 in Vietnam's medical device market through Pure Global AI's free database. is registered under number 1389 and manufactured by Biosensors Interventional Technologies Pte. Ltd.. The authorized representative in Vietnam is DAN THANH PHARMACEUTICAL TRADING COMPANY LIMITED.

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Biosensors Interventional Technologies Pte. Ltd., and 2 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
1 Competitors
2 Recent Registrations
1389
Registration Details
Vietnam MOH Registration: 1389
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Coronary stents release the drug Biolimus A9
VN: Hệ stent mạch vành giải phóng thuốc Biolimus A9
Hệ stent mạch vành giải phóng thuốc Biolimus A9 Biomatrix Neoflex

Registration Details

1389

Biomatrix Neoflex Drug Eluting Coronary Stent System

Company Information

Biosensors Europe SA

Switzerland

Technical Details

Cái

Dates and Status

Mar 31, 2022

Mar 30, 2024

Còn hiệu lực

Pricing

46200000 VND

Companies Making Similar Products
Companies providing products similar to "Coronary stents release the drug Biolimus A9"